These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 10047665
1. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y. J Thorac Cardiovasc Surg; 1999 Mar; 117(3):593-8. PubMed ID: 10047665 [Abstract] [Full Text] [Related]
2. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery]. Wang X, Zheng L, Zhang SY, Xie ZM, Yu H, Su XD, Wang JY, Huang ZF, Yang MT, Rong TH. Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559 [Abstract] [Full Text] [Related]
3. Improving clinical efficacy of computed tomographic scan in the preoperative assessment of patients with non-small cell lung cancer. Ratto GB, Frola C, Cantoni S, Motta G. J Thorac Cardiovasc Surg; 1990 Mar; 99(3):416-25. PubMed ID: 2155357 [Abstract] [Full Text] [Related]
4. The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer. Takamochi K, Nagai K, Yoshida J, Suzuki K, Ohde Y, Nishimura M, Takahashi K, Nishiwaki Y. J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1135-40. PubMed ID: 10838529 [Abstract] [Full Text] [Related]
6. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. Koike T, Koike T, Yamato Y, Yoshiya K, Toyabe S. J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962 [Abstract] [Full Text] [Related]
7. Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings. Takamochi K, Nagai K, Yoshida J, Suzuki K, Ohde Y, Nishimura M, Sasaki S, Nishiwaki Y. J Thorac Cardiovasc Surg; 2001 Aug; 122(2):325-30. PubMed ID: 11479506 [Abstract] [Full Text] [Related]
8. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3. Lee BE, Redwine J, Foster C, Abella E, Lown T, Lau D, Follette D. J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480 [Abstract] [Full Text] [Related]
9. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Al-Sarraf N, Aziz R, Gately K, Lucey J, Wilson L, McGovern E, Young V. Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738 [Abstract] [Full Text] [Related]
10. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study. De Leyn P, Stroobants S, De Wever W, Lerut T, Coosemans W, Decker G, Nafteux P, Van Raemdonck D, Mortelmans L, Nackaerts K, Vansteenkiste J. J Clin Oncol; 2006 Jul 20; 24(21):3333-9. PubMed ID: 16849747 [Abstract] [Full Text] [Related]
15. Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma. Okada M, Nishio W, Sakamoto T, Uchino K, Tsubota N. Ann Thorac Surg; 2003 Dec 20; 76(6):1828-32; discussion 1832. PubMed ID: 14667592 [Abstract] [Full Text] [Related]
16. Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas. Ye B, Cheng M, Ge XX, Geng JF, Li W, Feng J, Hu DZ, Zhao H. World J Surg Oncol; 2014 Feb 21; 12():42. PubMed ID: 24559138 [Abstract] [Full Text] [Related]
17. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures? Metin M, Citak N, Sayar A, Pekcolaklar A, Melek H, Kök A, Gurses A. J Thorac Oncol; 2011 Oct 21; 6(10):1713-9. PubMed ID: 21716145 [Abstract] [Full Text] [Related]
18. N2 lung cancer: outcome in patients with false-negative computed tomographic scans of the chest. Daly BD, Mueller JD, Faling LJ, Diehl JT, Bankoff MS, Karp DD, Rand WM. J Thorac Cardiovasc Surg; 1993 May 21; 105(5):904-10; discussion 910-1. PubMed ID: 8487569 [Abstract] [Full Text] [Related]
19. Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas. Liu Y, Kim J, Balagurunathan Y, Hawkins S, Stringfield O, Schabath MB, Li Q, Qu F, Liu S, Garcia AL, Ye Z, Gillies RJ. Med Phys; 2018 Jun 21; 45(6):2518-2526. PubMed ID: 29624702 [Abstract] [Full Text] [Related]
20. Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases. Fernandez FG, Kozower BD, Crabtree TD, Force SD, Lau C, Pickens A, Krupnick AS, Veeramachaneni N, Patterson GA, Jones DR, Meyers BF. J Thorac Cardiovasc Surg; 2015 Jan 21; 149(1):35-41, 42.e1. PubMed ID: 25439769 [Abstract] [Full Text] [Related] Page: [Next] [New Search]